Summit Therapeutics Total Non-Operating Income/Expense 2015-2024 | SMMT

Summit Therapeutics total non-operating income/expense for the twelve months ending December 31, 2024 was $0.005B, a 188.73% decline year-over-year.

  • Summit Therapeutics annual total non-operating income/expense for 2024 was $0.005B, a 188.73% decline from 2023.
  • Summit Therapeutics annual total non-operating income/expense for 2023 was $-0.005B, a 21.14% decline from 2022.
  • Summit Therapeutics annual total non-operating income/expense for 2022 was $-0.007B, a 177.03% increase from 2021.

Summit Therapeutics Total Non-Operating Income/Expense 2015-2024 | SMMT

  • Summit Therapeutics annual total non-operating income/expense for 2024 was $0.005B, a 188.73% decline from 2023.
  • Summit Therapeutics annual total non-operating income/expense for 2023 was $-0.005B, a 21.14% decline from 2022.
  • Summit Therapeutics annual total non-operating income/expense for 2022 was $-0.007B, a 177.03% increase from 2021.